Generation of CAR T-cells using γ-retroviral vector

Area of Science:

• Immunology
• Molecular Biology
• Biotechnology

Background:

• Chimeric antigen receptor (CAR) T cell therapy is a promising cancer treatment.
• Efficient gene transfer into primary T cells is essential for CAR T cell generation.
• Gammaretroviral vectors are a common tool for CAR T cell production in research and clinical settings.

Purpose of the Study:

• To provide a detailed protocol for generating CAR T cells using gammaretroviral vectors.
• To outline the key steps involved in viral particle production and T cell transduction.
• To ensure stable expression of CAR molecules on the surface of T cells.

Main Methods:

• Production of gammaretroviral particles via co-transfection of 293T cells with vector and packaging plasmids.
• Activation of primary T cells.
• Transduction of activated T cells with manufactured gammaretroviral particles.

Main Results:

• Successful generation of gammaretroviral particles capable of efficient gene transfer.
• Stable integration of the CAR transgene into the host genomic DNA of primary T cells.
• Demonstrated surface expression of the CAR molecule on transduced T cells.

Conclusions:

• Gammaretroviral vectors provide an effective method for generating CAR T cells.
• The described protocol enables the production of CAR T cells with stable CAR expression for therapeutic applications.
• This methodology supports the advancement of CAR T cell therapy in preclinical and clinical studies.